Literature DB >> 26825165

A Digital Squamous Cell Carcinoma Mimicking a Diabetic Foot Ulcer, With Early Inguinal Metastasis and Cancer-Related Lymphedema.

Hyun Chul Park1, Hyoung Il Kwon, Hyun Woo Kim, Jeong Eun Kim, Young Suck Ro, Joo Yeon Ko.   

Abstract

Although squamous cell carcinoma (SCC) is the second most common nonmelanoma skin cancer, clinicians have difficulty diagnosing SCC of the toe because its clinical features can mimic other less serious diseases. Clinicians are especially prone to misdiagnose SCC of the toe as diabetic foot ulcer in patients with diabetes mellitus because of the clinical similarity of the 2 ailments. SCC of the toe is generally considered to have a low risk of metastasis. Locoregional or distant metastases without bone or tendon involvement are particularly rare. The authors report here an interesting case of rapidly spreading SCC of the toe with metastasis to multiple lymph nodes and cancer-related lymphedema. Physicians should be aware of the possibility of malignancy when they encounter chronic and recalcitrant ulcerative lesions of the digits.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26825165     DOI: 10.1097/DAD.0000000000000412

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  2 in total

1.  Misdiagnosis of diabetic foot ulcer in patients with undiagnosed skin malignancies.

Authors:  Alexey V Lyundup; Maxim V Balyasin; Nadezhda V Maksimova; Marina V Kovina; Mikhail E Krasheninnikov; Tatiana G Dyuzheva; Sergey A Yakovenko; Svetlana A Appolonova; Helgi B Schiöth; Ilya D Klabukov
Journal:  Int Wound J       Date:  2021-10-29       Impact factor: 3.099

2.  Staphylococcus aureus Triggers Induction of miR-15B-5P to Diminish DNA Repair and Deregulate Inflammatory Response in Diabetic Foot Ulcers.

Authors:  Horacio A Ramirez; Irena Pastar; Ivan Jozic; Olivera Stojadinovic; Rivka C Stone; Nkemcho Ojeh; Joel Gil; Stephen C Davis; Robert S Kirsner; Marjana Tomic-Canic
Journal:  J Invest Dermatol       Date:  2017-12-19       Impact factor: 8.551

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.